Mankind Pharma Ltd (BSE) (stock symbol: MANKIND.BSE) is a publicly traded company listed on BSE, operating within the PHARMA sector. As of the latest trading session, Mankind Pharma Ltd (BSE) is trading at ₹2,116.57 with a market capitalization of 609.00B. The stock has experienced a decline of 2.64% in today's trading, reflecting bearish sentiment among market participants.
The day's trading range has been between ₹2,081.22 (low) and ₹2,132.44 (high), with an opening price of ₹2,163.52 compared to the previous close of ₹2,173.96. Approximately 1.40M shares have changed hands, indicating strong liquidity and active investor interest in this stock.
Key Market Metrics for MANKIND.BSE:
Investors tracking MANKIND.BSE should note that the P/E ratio of 23.11 indicates moderate market expectations for future growth. Understanding these fundamental metrics alongside technical price action gives investors a comprehensive view of Mankind Pharma Ltd (BSE)'s market position and future prospects on BSE.
The PHARMA sector has been particularly active for market participants. Companies within this sector demonstrate varying performance based on macroeconomic factors, regulatory changes, and company-specific developments. Mankind Pharma Ltd (BSE) continues to adapt to market dynamics while maintaining its competitive positioning.
For technical analysis, traders monitor several key levels for MANKIND.BSE: support at ₹2,081.22 and ₹2,173.96, and resistance at ₹2,132.44. The P/E ratio of 23.11 provides valuation context, helping investors determine if Mankind Pharma Ltd (BSE) is trading at a premium or discount relative to its earnings potential. Regular monitoring of quarterly results, management commentary, and sector-wide trends will help investors stay informed about MANKIND.BSE's trajectory on BSE.
The current live price of Mankind Pharma Ltd (BSE) (MANKIND.BSE) is ₹2,116.57 as of the most recent market data update on BSE. This price reflects the last traded value and changes in real-time during market hours. Today's trading session opened at ₹2,163.52, compared to the previous day's close of ₹2,173.96.
The intraday price action for MANKIND.BSE shows a high of ₹2,132.44 and a low of ₹2,081.22, giving the stock a daily trading range of approximately ₹51.22. The stock has experienced a decline of 2.64% in today's session. The total volume traded stands at approximately 1.40M shares.
Key Market Metrics for MANKIND.BSE:
Market participants tracking MANKIND.BSE should note that these prices are live and updated from market data providers. The market cap of 609.00B places Mankind Pharma Ltd (BSE) among significant companies listed on BSE. Trading volume of 1.40M shares suggests strong liquidity and active investor interest in this stock.
Understanding the price history of Mankind Pharma Ltd (BSE) (MANKIND.BSE) is essential for both technical and fundamental analysis. The stock's current price of ₹2,116.57 can be better understood in the context of its recent trading patterns and long-term trends on BSE.
Today's price action shows MANKIND.BSE opening at ₹2,163.52 compared to the previous close of ₹2,173.96. The intraday high of ₹2,132.44 and low of ₹2,081.22 represent the price boundaries for today's trading session. The negative movement of 2.64% provides insight into the day's market sentiment toward Mankind Pharma Ltd (BSE).
For technical analysis, traders monitor several key levels for MANKIND.BSE:
The P/E ratio of 23.11 provides a valuation benchmark comparing Mankind Pharma Ltd (BSE)'s stock price to its earnings per share. These fundamental metrics, combined with technical price action, give investors a comprehensive view of MANKIND.BSE's current market position and future prospects on BSE.
Investors are advised to use the interactive chart above to analyze MANKIND.BSE's price trends across different timeframes — from intraday 1D charts for short-term traders to 1Y charts for long-term investors. The combination of fundamental analysis and technical chart patterns helps in making well-informed decisions about Mankind Pharma Ltd (BSE) stock in the PHARMA sector.
Indian investors looking to purchase Mankind Pharma Ltd (BSE) (MANKIND.BSE) shares have several reliable options through registered stockbrokers and trading platforms. The process of buying MANKIND.BSE shares in India involves opening a demat and trading account with a SEBI-registered broker, completing the KYC (Know Your Customer) process, and funding the account to start trading. Below are the most popular platforms for investing in MANKIND.BSE and other stocks on BSE.
Zerodha is India's largest retail stockbroker by active clients and offers a seamless platform for buying MANKIND.BSE shares. With Zerodha's Kite platform, you can trade Mankind Pharma Ltd (BSE) stocks on NSE and BSE with zero brokerage on equity delivery trades. The account opening process is fully digital and can be completed in minutes. Open a Zerodha account here to start investing in MANKIND.BSE with zero brokerage on delivery trades and flat €20 per trade on intraday and F&O.
Groww offers an intuitive mobile-first investment platform that is perfect for beginners looking to buy Mankind Pharma Ltd (BSE) shares. With a simple interface and educational resources, Groww makes it easy to invest in MANKIND.BSE and thousands of other stocks and mutual funds. The platform offers zero account opening fees and zero brokerage on equity delivery. Sign up on Groww to begin your investment journey with Mankind Pharma Ltd (BSE) shares.
Angel One is another excellent choice for trading MANKIND.BSE stocks, offering advanced charting tools, research reports, and expert recommendations. The platform provides free equity delivery trades and a powerful mobile trading app. Angel One's research team publishes regular analysis on Mankind Pharma Ltd (BSE) and other PHARMA sector stocks to help you make informed decisions. Open an Angel One account and get access to expert stock recommendations and advanced trading tools.
Steps to Buy MANKIND.BSE Shares in India:
Disclaimer: Investments in the stock market are subject to market risks. Past performance does not guarantee future returns. Please consult a financial advisor before making investment decisions.
Here are other stocks in the PHARMA sector that investors tracking Mankind Pharma Ltd (BSE) (MANKIND.BSE) may also be interested in. These companies operate in similar business areas and their performance can provide context for sector-wide trends on BSE.
The current live price of Mankind Pharma Ltd (BSE) (MANKIND.BSE) is ₹ as traded on BSE. This price updates in real-time during market hours. Investors tracking MANKIND.BSE can use the interactive chart on this page to monitor price movements across different timeframes and make informed trading decisions.
Indian investors can buy MANKIND.BSE shares by opening a demat and trading account with any SEBI-registered stockbroker such as Zerodha, Groww, or Angel One. The process involves completing online KYC verification with your Aadhaar and PAN cards, funding your trading account, and placing a buy order for the desired quantity on the BSE exchange. We recommend comparing brokerage fees and platform features before choosing a broker.
Mankind Pharma Ltd (BSE) operates in the PHARMA sector and is listed on BSE. The company's stock performance is influenced by sector-specific trends, economic conditions, regulatory developments, and company-specific factors within the PHARMA industry. Investors should monitor sector performance alongside individual stock metrics for a comprehensive view.
The current market capitalization of Mankind Pharma Ltd (BSE) is approximately 609.00B, placing it in the mid-cap category on BSE. The P/E ratio stands at 23.11, which provides a valuation benchmark comparing the stock price to earnings per share. These metrics help investors assess whether MANKIND.BSE is fairly valued compared to peers in the PHARMA sector.
Whether MANKIND.BSE (Mankind Pharma Ltd (BSE)) is a good investment depends on your individual financial goals, risk tolerance, and investment horizon. The stock currently trades at ₹2,116.57 with a negative change of 2.64% today. The P/E ratio of 23.11 suggests moderate valuation. We recommend consulting a SEBI-registered financial advisor and using our interactive chart tools to conduct your own research before making investment decisions.